PimedBio

ABOUT US
About Us
We create new treatments
based on cutting-edge approaches.
PLATFORM
Platform
We create new treatments
based on cutting-edge approaches.
- Platform Technology
PIPELINE
Pipeline
We create new treatments
based on cutting-edge approaches.
PR
PR
We create new treatments
based on cutting-edge approaches.
- News
- Notice
- IR
CAREER
CAREER
We create new treatments
based on cutting-edge approaches.
- Recruitment notice
- Join us

Drugging the

Undruggables

Shaping Tomorrow with Next-Gen Therapeutics

SCROLL

About Us

Shaping Tomorrow with Next-Gen Therapeutics

PimedBio is moving forward step by step to realize the dream of better human health.

Platform

PimedBio PLATFORM TECHNOLOGY 01

Target Discovery

By analyzing big data, we identify novel targets—proteins engaged in multiple key pathways activated in disease-specific contexts

Platform

PimedBio PLATFORM TECHNOLOGY 02

Innovative Drug Design

Against the identified target, we design, ensuring safety and efficacy, small molecules leads and candidates based on various modalities such as protein targeted degraders(PTD), bispecific small-molecules(BSM) and inhibitor-drug conjugates(IDC).

Pipeline

Pioneering
First-in-Class
Therapeutics

PimedBio is constantly pursuing
challenges and innovations for the
future of human health.

Oncology

Our oncology drug discovery focuses on integrative controls of the complex, heterogeneous, and plastic nature of cancer by targeting cancer stem cells and the tumor-friendly microenvironment, as well as inhibiting growth. We believe that these efforts will lead to the treatment of cancer without metastasis and recurrence near future.

Immunology

By targeting both autoimmunity and fibrogenesis through integrated regulation, our drug discovery aims to develop therapies for autoimmune diseases while simultaneously preventing fibrogenesis.